Instead, the soft matrix caused these alterations via epithelial tumor cells through triggering upregulation of the cyclooxygenase 2 (COX2) pathway activity and secretion of fibroblast growth factor 2 (FGF2), leading to subsequent immune suppression. The gene discussed is PTGS2; the disease is neoplasm.